Thirty-three adults ages > @ y with MCI were randomized to receive a supplement rich in the long-chain -@ PUFAs eicosapentaenoic acid ( EPA ; @ g EPA + @ g docosahexaenoic acid DHA/d ; n = @ ) or DHA ( @ g DHA + @ g EPA/d ; n = @ ) , versus -@ PUFA linoleic acid ( LA ; @ g/d ; n = @ ) for @ mo. .